Literature DB >> 23917451

Recovery of native erythropoietin in a patient with erythropoietin-associated pure red cell aplasia.

Kristina M Prus1, Mohamad M Al-Rahawan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23917451     DOI： 10.1007/s00467-013-2580-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

Review 1.  Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.

Authors:  Iain C Macdougall; Simon D Roger; Angel de Francisco; David J A Goldsmith; Huub Schellekens; Hans Ebbers; Wolfgang Jelkmann; Gérard London; Nicole Casadevall; Walter H Hörl; David M Kemeny; Carol Pollock
Journal:  Kidney Int       Date:  2012-02-15       Impact factor: 10.612

2.  Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.

Authors:  Parnell Mattison; Kiran Upadhyay; Jennifer E Wilcox; Asha Moudgil; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2010-01-21       Impact factor: 3.714

Review 3.  Epoetin-associated pure red cell aplasia: past, present, and future considerations.

Authors:  June M McKoy; Robin E Stonecash; Denis Cournoyer; Jerome Rossert; Allen R Nissenson; Dennis W Raisch; Nicole Casadevall; Charles L Bennett
Journal:  Transfusion       Date:  2008-05-14       Impact factor: 3.157
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.